UCB BIOPHARMA SPRL GRANTED PATENT FOR FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY.
UCB Biopharma SPRL operates as a pharmaceutical company. The Company manufactures and supplies a wide range of medicines and drugs […]
Blockchain and Patent Law Research
UCB Biopharma SPRL operates as a pharmaceutical company. The Company manufactures and supplies a wide range of medicines and drugs […]